Drug Profile
Research programme: submicron migraine therapeutics - iCeutica
Alternative Names: ICE-1209; ICE-1210; ICE-1211Latest Information Update: 27 Apr 2023
Price :
$50
*
At a glance
- Originator iCeutica
- Class Tryptamines
- Mechanism of Action Serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Migraine
Most Recent Events
- 27 Apr 2023 Discontinued - Preclinical for Migraine in USA (Intranasal)
- 27 Apr 2023 Discontinued - Preclinical for Migraine in USA (Sublingual)
- 28 Nov 2018 No recent reports of development identified for preclinical development in Migraine in USA (Intranasal)